Faiz Ul Amin
Overview
Explore the profile of Faiz Ul Amin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
660
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wei H, Withrow J, Rakshit J, Ul Amin F, Nahm J, Mowry F, et al.
Aging Dis
. 2024 Mar;
15(6):2752-2769.
PMID: 38502590
Alzheimer's disease (AD) is characterized by the presence of two hallmark pathologies: the accumulation of Amyloid beta (Aβ) and tau proteins in the brain. There is a growing body of...
2.
Salman M, Rizwana R, Khan H, Munir I, Hamayun M, Iqbal A, et al.
Artif Cells Nanomed Biotechnol
. 2019 Jun;
47(1):2465-2472.
PMID: 31187657
() is an aerobic gram-negative, non-spore forming, rod-shaped bacterium. It accelerates the decline in lung function and ultimately leads to increased mortality and morbidity rate. Survival and virulence of is...
3.
Kafash Hoshiar A, Le T, Ul Amin F, Kim M, Yoon J
Nanomaterials (Basel)
. 2017 Dec;
8(1).
PMID: 29271927
The blood-brain barrier (BBB) hinders drug delivery to the brain. Despite various efforts to develop preprogramed actuation schemes for magnetic drug delivery, the unmodeled aggregation phenomenon limits drug delivery performance....
4.
Ali T, Kim T, Rehman S, Khan M, Ul Amin F, Khan M, et al.
Mol Neurobiol
. 2017 Nov;
55(7):6076-6093.
PMID: 29170981
Well-established studies have shown an elevated level of reactive oxygen species (ROS) that induces oxidative stress in the Alzheimer's disease (AD) patient's brain and an animal model of AD. Herein,...
5.
Kafash Hoshiar A, Le T, Ul Amin F, Kim M, Yoon J
Annu Int Conf IEEE Eng Med Biol Soc
. 2017 Oct;
2017:885-888.
PMID: 29060014
Despite the promising results in magnetic nanoparticles (MNPs) based targeted drug delivery (TDD), the aggregation of the magnetic nanoparticles deteriorates targeting performance. This paper aims to introduce a magnetic actuation...
6.
Kim M, Rehman S, Ul Amin F, Kim M
Nanomedicine
. 2017 Jul;
13(8):2533-2544.
PMID: 28736294
Amyloid-beta (Aβ) plaques and neurofibrillary tangles (NFTs) are the main hallmarks considered to be associated with neuroinflammation in Alzheimer's disease (AD). Recently, nanoparticle-based targeted drug delivery approaches have been found...
7.
Ul Amin F, Kafash Hoshiar A, Do T, Noh Y, Shah S, Khan M, et al.
Nanoscale
. 2017 May;
9(30):10619-10632.
PMID: 28534925
Alzheimer's disease (AD) is the most prevalent age-related neurodegenerative disease, pathologically characterized by the accumulation of aggregated amyloid beta (Aβ) in the brain. Here, we describe for the first time...
8.
Ul Amin F, Shah S, Badshah H, Khan M, Kim M
J Nanobiotechnology
. 2017 Feb;
15(1):12.
PMID: 28173812
Background: In order to increase the bioavailability of hydrophilic unstable drugs like anthocyanins, we employed a polymer-based nanoparticles approach due to its unique properties such as high stability, improved bioavailability...
9.
Ul Amin F, Shah S, Kim M
Sci Rep
. 2017 Jan;
7:40753.
PMID: 28098243
Increasing evidence demonstrates that β-amyloid (Aβ) elicits oxidative stress, which contributes to the pathogenesis and disease progression of Alzheimer's disease (AD). The aims of the present study were to determine...
10.
Shah S, Ul Amin F, Khan M, Abid M, Rehman S, Kim T, et al.
J Neuroinflammation
. 2016 Nov;
13(1):286.
PMID: 27821173
Background: Glutamate-induced excitotoxicity, oxidative damage, and neuroinflammation are believed to play an important role in the development of a number of CNS disorders. We recently reported that a high dose...